Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, VARZOS, VARZOS
Symptoms: Paraesthesia, Rash
Clinical narrative: Rashes on body; 1st dose Jan2021, 2nd not yet; Tingling in legs; Numbness in legs/ numbness in her feet; tingling and numbness in her legs which was painful; Uncomfortable; Kept up at night; This case was reported by a consumer via call center representative and described the occurrence of tingling of extremity in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis, ELASOMERAN (COVID 19 VACCINE MODERNA) for prophylaxis, TOZINAMERAN (PFIZER BIONTECH COVID-19 BOOSTER) for prophylaxis, TOZINAMERAN (PFIZER COVID VACCINE) for prophylaxis and TOZINAMERAN (PFIZER COVID VACCINE) for prophylaxis.   In January 2021, the patient received the 1st dose of Shingrix. On an unknown date, the patient did not receive the 2nd dose of Shingrix, COVID 19 VACCINE MODERNA and PFIZER BIONTECH COVID-19 BOOSTER. In March 2021, the patient received the 2nd dose of PFIZER COVID VACCINE. In February 2021, the patient received the 1st dose of PFIZER COVID VACCINE. In March 2021, between 2 and 3 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced tingling of extremity, numbness in leg, leg pain, discomfort and nocturnal awakening. On an unknown date, the patient experienced generalized rash and incomplete course of vaccination. On an unknown date, the outcome of the tingling of extremity, numbness in leg, leg pain, discomfort, nocturnal awakening, generalized rash and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the tingling of extremity, numbness in leg, leg pain, discomfort, nocturnal awakening and generalized rash to be related to Shingrix.     Additional Information: GSK Receipt Date: 06-Feb-2023 Reporter's Comments: In February 2021, the patient received the first Covid (Pfizer) vaccine, and in March 2021, received the second COVID (Pfizer) vaccine.  The patient reported that about 1 week after receiving the second COVID vaccine, the patient experienced tingling and numbness in legs which was painful, uncomfortable, and kept the patient up a night and this lasted for quite a while.  The patient also received the first (Pfizer) and second (Moderna) COVID boosters and after the first COVID booster, the patient again experienced tingling and numbness but it was not as bad as the first experience.  After the second COVID booster, the patient did not experience numbness and tingling. However, once in a while, the patient gets numbness in feet but not as bad as it used to.  Lately, the patient had been getting rashes on the body.  The reporter gave permission to follow-up. Additional Supportive Information: Till the time of reporting, the patient did not receive the second dose of Shingrix which led to incomplete course of vaccination. It was unknown if the reporter considered the tingling of extremity, numbness in leg, leg pain, discomfort, nocturnal awakening and generalized rash to be related to 1st and 2nd of Pfizer Covid vaccine, Covid-19 vaccine Moderna and Pfizer Biontech Covid-19 Booster